A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5)

Neurochemistry International

Volumn 58, Issue 2, 2011, Pages 206-214

  Kaźmierczak, Anna ^a   Czapski, Grzegorz A ^a   Adamczyk, Agata ^a   Gajkowska, Barbara ^a   Strosznajder, Joanna B ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Synuclein; Apoptosis; Bax protein; Cdk5 activator p39; Cyclin dependent kinase 5; Neuronal Cdk5 activator (p25 p35); Non A component of Alzheimer's disease amyloid protein; Oxidative stress; p53 protein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; BML 259; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; FREE RADICAL; N TERT BUTYL ALPHA PHENYLNITRONE; PROTEIN BAX; PROTEIN P39; PROTEIN P53; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BETA RHYTHM; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EVOKED RESPONSE; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYCLIN-DEPENDENT KINASE 5; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; NEURONS; PC12 CELLS; RATS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78651256132     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.11.018     Document Type: Article

References (83)

1. A. Adamczyk, G.A. Czapski, A. Kaźmierczak, and J.B. Strosznajder Effect of N-methyl-d-aspartate (NMDA) receptor antagonists on alpha-synuclein-evoked neuronal nitric oxide synthase activation in the rat brain Pharmacol. Rep. 61 2009 1078 1085
2. A. Adamczyk, M. Kacprzak, and A. Kazmierczak Alpha-synuclein decreases arachidonic acid incorporation into rat striatal synaptoneurosomes Folia Neuropathol. 45 2007 230 235
3. A. Adamczyk, A. Kazmierczak, and J.B. Strosznajder Alpha-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide Neurochem. Int. 49 2006 407 412
4. 2+ channels Neuroreport 7 2006 1883 1886
5. K.T. Akama, and L.J. Van Eldik Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-a (TNFa)-dependent, and involves a TNFa receptor associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism J. Biol. Chem. 275 2000 7918 7924
6. A.M. Bodles, D.J. Guthrie, B. Greer, and G.B. Irvine Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity J. Neurochem. 78 2001 384 395
7. A.M. Bodles, D.J. Guthrie, P. Harriott, P. Campbell, and G.B. Irvine Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils Eur. J. Biochem. 267 2000 2186 2194
8. R. Borghi, L. Giliberto, A. Assini, A. Delacourte, G. Perry, M.A. Smith, P. Strocchi, D. Zaccheo, and M. Tabaton Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy Neurology 58 2002 589 592
9. H. Braak, K. Del Tredici, U. Rüb, R.A. de Vos, E.N. Jansen Steur, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol. Aging 24 2003 197 211
10. A.J. Brookes, and D. St Clair Synuclein proteins and Alzheimer's disease Trends Neurosci. 17 1994 404 405
11. B. Bu, J. Li, P. Davies, and I. Vincent Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model J. Neurosci. 22 2002 6515 6525
12. D. Campion, C. Martin, R. Heilig, F. Charbonnier, V. Moreau, J.M. Flaman, J.L. Petit, D. Hannequin, A. Brice, and T. Frebourg The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease Genomics 26 1995 254 257
13. R.C. Crumrine, A.L. Thomas, and P.F. Morgan Attenuation of p53 expression protects against focal ischemic damage in transgenic mice J. Cereb. Blood Flow Metab. 14 1994 887 891
14. R. Dargusch, D. Piasecki, S. Tan, Y. Liu, and D. Schubert The role of Bax in glutamate-induced nerve cell death J. Neurochem. 76 1 2001 295 301
15. S.M. de la Monte, Y.K. Sohn, and J.R. Wands Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease J. Neurol. Sci. 152 1997 73 83
16. P. Desplats, H.J. Lee, E.J. Bae, C. Patrick, E. Rockenstein, L. Crews, B. Spencer, E. Masliah, and S.J. Lee Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein Proc. Natl. Acad. Sci. U.S.A. 106 2009 13010 13015
17. O.M. El-Agnaf, R. Jakes, M.D. Curran, D. Middleton, R. Ingenito, E. Bianchi, A. Pessi, D. Neill, and A. Wallace Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments FEBS Lett. 440 1998 71 75
18. O.M. El-Agnaf, S.A. Salem, K.E. Paleologou, L.J. Cooper, N.J. Fullwood, M.J. Gibson, M.D. Curran, J.A. Court, D.M. Mann, S. Ikeda, M.R. Cookson, J. Hardy, and D. Allsop Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma FASEB J. 17 2003 1945 1947
19. J.M. Frade Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones J. Cell. Sci. 113 7 2000 1139 1148
20. A. Gentile, G. Amadoro, V. Corsetti, M.T. Ciotti, A. Serafino, and P. Calissano Spontaneous aggregation and altered intracellular distribution of endogenous alpha-synuclein during neuronal apoptosis J. Alzheimers Dis. 13 2 2008 151 160
21. J. Goers, A.B. Manning-Bog, A.L. McCormack, I.S. Millett, S. Doniach, D.A. Di Monte, V.N. Uversky, and A.L. Fink Nuclear localization of alpha-synuclein and its interaction with histones Biochemistry 42 28 2003 8465 8471
22. H. Han, P.H. Weinreb, and P.T. Lansbury Jr. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2 1995 163 169
23. S. Haupt, M. Berger, Z. Goldberg, and Y. Haupt Apoptosis - the p53 network J. Cell. Sci. 116 2003 4077 4085
24. Y. Huang, F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain Neurosci. Lett. 373 2005 115 118
25. A. Hunya, I. Földi, V. Szegedi, K. Soós, M. Zarándi, A. Szabó, D. Zádori, B. Penke, and Z.L. Datki Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Abeta(1-42) and NAC treatment Brain Res. Bull. 75 5 2008 648 654
26. K. Ishizawa, T. Komori, N. Arai, T. Mizutani, and T. Hirose Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: a quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system) Neuropathology 28 2008 249 257 (Pubitemid 351623763)
27. A. Iwai, M. Yoshimoto, E. Masliah, and T. Saitoh Non-A beta component of Alzheimer's disease amyloid, (NAC) is amyloidogenic Biochemistry 34 1995 10139 10145
28. K.A. Jellinger Lewy body-related alpha-synucleinopathy in the aged human brain J. Neural Transm. 111 2004 1219 1235
29. P.H. Jensen, P. Hojrup, H. Hager, M.S. Nielsen, L. Jacobsen, O.F. Olesen, J. Gliemann, and R. Jakes Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC Biochem. J. 323 1997 539 546
30. M.D. Johnson, Y. Kinoshita, H. Xiang, S. Ghatan, and R.S. Morrison Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation J. Neurosci. 19 1999 2996 3006
31. B. Kaltschmidt, M. Uherek, B. Volk, P.A. Baeuerle, and C. Kaltschmidt Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 94 1997 2642 2647
32. A. Kazmierczak, A. Adamczyk, and J.B. Strosznajder alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells Neurochem. Int. 53 2008 263 269
33. G. Kusakawa, T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, and S. Hisanaga Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25 J. Biol. Chem. 275 2000 17166 17172
34. F.M. LaFerla, C.K. Hall, L. Ngo, and G. Jay Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice J. Clin. Invest. 98 1996 1626 1632
35. A. Lakkaraju, J.M. Dubinsky, W.C. Low, and Y.E. Rahman Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes J. Biol. Chem. 276 2001 32000 32007
36. H.G. Lee, G. Casadesus, X. Zhu, R.J. Castellani, A. McShea, G. Perry, R.B. Petersen, V. Bajic, and M.A. Smith Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease Neurochem. Int. 54 2 2009 84 88
37. H.J. Lee, J.E. Suk, C. Patrick, E.J. Bae, J.H. Cho, S. Rho, D. Hwang, E. Masliah, and S.J. Lee Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies J. Biol. Chem. 285 2010 9262 9272
38. J.H. Lee, H.S. Kim, S.J. Lee, and K.T. Kim Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death J. Cell. Sci. 120 2007 2259 2271
39. K.Y. Lee, A.W. Clark, J.L. Rosales, K. Chapman, T. Fung, and R.N. Johnston Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain Neurosci. Res. 34 1999 21 29
40. M.S. Lee, S.C. Kao, C.A. Lemere, W. Xia, H.C. Tseng, Y. Zhou, R. Neve, M.K. Ahlijanian, and L.H. Tsai APP processing is regulated by cytoplasmic phosphorylation J. Cell. Biol. 163 2003 83 95
41. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, and L.H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364
42. P.H. Lee, G. Lee, H.J. Park, O.Y. Bang, I.S. Joo, and K. Huh The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy J. Neural. Transm. 113 2006 1435 1439
43. Y. Liu, and D. Schubert Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity J. Neurochem. 71 1998 2322 2329
44. J.P. Lopes, C.R. Oliveira, and P. Agostinho Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides Cell Cycle 8 1 2009 97 104
45. S. Love Apoptosis and brain ischaemia Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2 2003 267 282
46. P.K. Mandal, J.W. Pettegrew, E. Masliah, R.L. Hamilton, and R. Mandal Interaction between Aβ peptide and α-synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease Neurochem. Res. 31 2006 1153 1162
47. L.J. Martin, Z. Liu, J. Pipino, B. Chestnut, and M.A. Landek Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex Cereb. Cortex 19 6 2009 1273 1293
48. E. Masliah, A. Sisk, M. Mallory, L. Mucke, D. Schenk, and D. Games Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease J. Neurosci. 16 1996 5795 5811
49. I. Mikolaenko, O. Pletnikova, C.H. Kawas, R. O'Brien, S.M. Resnick, B. Crain, and J.C. Troncoso Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA) J. Neuropathol. Exp. Neurol. 64 2005 156 162
50. J. Nahalkova, I. Volkmann, M. Aoki, B. Winblad, N. Bogdanovic, L.O. Tjernberg, and H. Behbahani CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2 Neurochem. Int. 56 2010 67 76
51. R. Nath, M. Davis, A.W. Probert, N.C. Kupina, X. Ren, G.P. Schielke, and K.K. Wang Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells Biochem. Biophys. Res. Commun. 274 2000 16 21
52. M.D. Nguyen, R.C. Larivire, and J.P. Julien Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions Neuron 30 2001 135 147
53. C. Otth, I.I. Concha, T. Arendt, J. Stieler, R. Schliebs, C. González-Billault, and R.B. Maccioni APP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576 J. Alzheimers Dis. 4 2002 417 430
54. E. Paradis, H. Douillard, M. Koutroumanis, C. Goodyer, and A. LeBlanc Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons J. Neurosci. 16 23 1996 7533 7539
55. L. Parkkinen, P. Hartikainen, and I. Alafuzoff Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms Clin. Neuropathol. 26 2007 276 283
56. G.N. Patrick, L. Zukerberg, M. Nikolic, de la MonteF S., DikkesF P., and TsaiF L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 1999 615 622
57. O. Pletnikova, N. West, M.K. Lee, G.L. Rudow, R.L. Skolasky, T.M. Dawson, L. Marsh, and J.C. Troncoso Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases Neurobiol.Aging 26 2005 1183 1192
58. B.M. Polster, and G. Fiskum Mitochondrial mechanisms of neural cell apoptosis J. Neurochem. 90 6 2004 1281 1289
59. R. Raghupathi Cell death mechanisms following traumatic brain injury Brain Pathol. 14 2 2004 215 222
60. J. Renzing, S. Hansen, and D.P. Lane Oxidative stress is involved in the UV activation of p53 J. Cell. Sci. 109 5 1996 1105 1112
61. G. Schmid, J.B. Strosznajder, and J. Wesierska-Gadek Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors Mol. Neurobiol. 34 2006 27 50
62. D. Schubert, G. Cole, T. Saitoh, and T. Oltersdorf Amyloid beta protein precursor is a mitogen Biochem. Biophys. Res. Commun. 162 1989 83 88
63. J.H. Seo, J.C. Rah, S.H. Choi, J.K. Shin, K. Min, H.S. Kim, C.H. Park, S. Kim, E.M. Kim, S.H. Lee, S. Lee, S.W. Suh, and Y.H. Suh Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway FASEB J. 16 2002 1826 1828
64. R. Shaltiel-Karyo, M. Frenkel-Pinter, N. Egoz-Matia, A. Frydman-Marom, D.E. Shalev, D. Segal, and E. Gazit Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson's disease model flies PLoS One 5 11 2010 13863
65. P.D. Smith, S.J. Crocker, V. Jackson-Lewis, K.L. Jordan-Sciutto, S. Hayley, M.P. Mount, M.J. O'Hare, S. Callaghan, R.S. Slack, S. Przedborski, H. Anisman, and D.S. Park Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 100 2003 13650 13655
66. R.P. Strosznajder, H. Jesko, and A. Adamczyk Effect of aging and oxidative/genotoxic stress on poly(ADP-ribose) polymerase-1 activity in rat brain Acta Biochim. Pol. 52 4 2005 909 914
67. M. Sulg, A. Kirjavainen, K. Pajusola, H. Bueler, J. Ylikoski, M. Laiho, and U. Pirvola Differential sensitivity of the inner ear sensory cell populations to forced cell cycle re-entry and p53 induction J. Neurochem. 112 6 2010 1513 1526
68. J.Y. Sung, S.M. Park, C.H. Lee, J.W. Um, H.J. Lee, J. Kim, Y.J. Oh, S.T. Lee, S.R. Paik, and K.C. Chung Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases J. Biol. Chem. 280 2005 25216 25224
69. S. Tanaka, M. Takehashi, N. Matoh, S. Iida, T. Suzuki, S. Futaki, and H. Hamada Generation of reactive oxygen species and activation of NF-kappaB by non-Abeta component of Alzheimer's disease amyloid J. Neurochem. 82 2002 305 315
70. S. Tanaka, M. Takehashi, N. Matoh, and K. Ueda α-synuclein/NACP and neurodegeneration TanakaF C. McGeerF P.L. IharaF Y. Neuroscientific Basis of Dementia 2001 Birkhauser-Verlag Basel 137 141
71. B. Tian, Q. Yang, and Z. Mao Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death Nat. Cell Biol. 11 2 2009 211 218 (Erratum in Nat. Cell Biol. 11(8), 1042)
72. L.H. Tsai, I. Delalle, V.S. Caviness Jr., T. Chae, and E. Harlow p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 Nature 371 1994 419 423
73. L.H. Tsai, M.S. Lee, and J. Cruz Cdk5, a therapeutic target for Alzheimer's disease? Biochim. Biophys. Acta 1697 2004 137 142 (Pubitemid 38326767)
74. K. Ueda, H. Fukushima, E. Masliah, Y. Xia, A. Iwai, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara, and T. Saitoh Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90 1993 11282 11286
75. V.N. Uversky, and A.L. Fink Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle FEBS Lett. 522 2002 9 13
76. H. Wu, and G. Lozano NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress J. Biol. Chem. 269 1994 20067 72004
77. H. Xiang, Y. Kinoshita, C.M. Knudson, S.J. Korsmeyer, P.A. Schwartzkroin, and R.S. Morrison Bax involvement in p53-mediated neuronal cell death J. Neurosci. 18 4 1998 1363 1373
78. S. Xu, M. Zhou, S. Yu, Y. Cai, A. Zhang, K. Uéda, and P. Chan Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells Biochem. Biophys. Res. Commun. 342 1 2006 330 335
79. M. Yoshimoto, A. Iwai, D. Kang, D.A. Otero, Y. Xia, and T. Saitoh NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation Proc. Natl. Acad. Sci. U.S.A. 92 1995 9141 9145
80. Y. Yuan, J. Jin, B. Yang, W. Zhang, J. Hu, Y. Zhang, and N.H. Chen Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway Cell Mol. Neurobiol. 28 2008 21 33
81. N. Zamzami, C. Maisse, D. Metivier, and G. Kroemer Measurement of membrane permeability and the permeability transition in mitochondria L. Pon, A. Schon, Methods in Cell biology: Mitochondria 2007 Academic Press San Diego 327 340
82. J. Zhang, P.K. Krishnamurthy, and G.V. Johnson Cdk5 phosphorylates p53 and regulates its activity J. Neurochem. 81 2002 307 313
83. X. Zhu, H.G. Lee, G. Perry, and M.A. Smith Alzheimer disease, the two-hit hypothesis: an update Biochim Biophys Acta. 1772 2007 494 502